To evaluate whether ADI1 y RRP1 are associated with clinical outcomes in patients with lung adenocarcinoma, we analyzed their mRNA expression levels according to disease progression and overall survival by way of the KM Plotter web-site (https://kmplot.com), accessed on 1 July 2022 (Figure 8). This evidence concerns the gene ADI1 and lung adenocarcinoma.